Vitamin maker agrees to settle in price-fixing case

- Last updated on GMT

Related tags: United states

German chemicals firm Merck KGaA, one the vitamin manufacturers
involved in the price fixing allegations, has reached a settlement
and is co-operating with the plaintiffs, reported the New York
Times today.

The company has agreed to pay an undisclosed sum, and will provide documents and witnesses to bolster the plaintiffs' case, said the report.

Other defendants in the case include Roche, BASF and Aventis. The US Supreme Court said this week that it would hear an appeal from the vitamin makers, being sued by firms from Australia, Ecuador, Panama and Ukraine.The companies have challenged the lawsuit, first filed in 2000, claiming that they cannot be sued in the US for activities carried out abroad.

Some manufacturers have already pleaded guilty to antitrust charges in the United States, paying fines of $900 million. The European Union has also charged the companies.

Related topics: Vitamins & premixes

Related products

show more

20 Years Palm Tocotrienols Brain Health Research

20 Years Palm Tocotrienols Brain Health Research

ExcelVite Sdn. Bhd. | 25-Sep-2019 | Technical / White Paper

Research of Vitamin E tocotrienol in brain health and neuroprotection began twenty years ago.
Today, other health benefits have been discovered...

MenaQ7® Partners Benefit From K2 Outreach

MenaQ7® Partners Benefit From K2 Outreach

NattoPharma USA, Inc. | 22-Apr-2019 | Case Study

MenaQ7® K2 as MK-7 provides health benefits for all ages. That is a fact clinically proven by NattoPharma and communicated to practitioners and consumers...

Breakthrough in Women's Health

Breakthrough in Women's Health

Biosearch Life | 08-Apr-2019 | Clinical Study

A new study performed on women with polycystic ovary syndrome (PCOS) and fertility problems has been published in Gynecological Endocrinology. Results...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars